-
Loading metrics
Open Access
Peer-reviewed
Research Article
Predicting In Vivo Anti-Hepatofibrotic Drug Efficacy Based on In Vitro High-Content Analysis
-
Baixue Zheng,
Affiliations Computation and Systems Biology Program, Singapore-MIT Alliance, National University of Singapore, Singapore, Singapore, Institute of Bioengineering and Nanotechnology, A*STAR, Singapore, Singapore, Mechanobiology Institute, National University of Singapore, Singapore, Singapore
⨯ -
Looling Tan,
Affiliation Institute of Bioengineering and Nanotechnology, A*STAR, Singapore, Singapore
⨯ -
Xuejun Mo,
Affiliations Institute of Bioengineering and Nanotechnology, A*STAR, Singapore, Singapore, Department of Chemistry, Faculty of Science, National University of Singapore, Singapore, Singapore
⨯ -
Weimiao Yu,
Affiliations Imaging Informatics Division, Bioinformatics Institute, A*STAR, Singapore, Singapore, Central Imaging Facility, Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore
⨯ -
Yan Wang,
Affiliations Institute of Bioengineering and Nanotechnology, A*STAR, Singapore, Singapore, Department of Hepatobiliary Surgery, Southern Medical University Affiliated Zhujiang Hospital, Guangzhou, China
⨯ -
Lisa Tucker-Kellogg,
Affiliations Computation and Systems Biology Program, Singapore-MIT Alliance, National University of Singapore, Singapore, Singapore, Mechanobiology Institute, National University of Singapore, Singapore, Singapore
⨯ -
Roy E. Welsch,
Affiliations Computation and Systems Biology Program, Singapore-MIT Alliance, National University of Singapore, Singapore, Singapore, Engineering Systems Division, Sloan School of Management, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America
⨯ -
Peter T. C. So,
Affiliations Computation and Systems Biology Program, Singapore-MIT Alliance, National University of Singapore, Singapore, Singapore, Singapore-MIT Alliance for Research and Technology, BioSyM, Singapore, Singapore, Department of Mechanical Engineering and Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America
⨯ -
Hanry Yu
* E-mail: hanry_yu@nuhs.edu.sg
Affiliations Computation and Systems Biology Program, Singapore-MIT Alliance, National University of Singapore, Singapore, Singapore, Institute of Bioengineering and Nanotechnology, A*STAR, Singapore, Singapore, Mechanobiology Institute, National University of Singapore, Singapore, Singapore, Singapore-MIT Alliance for Research and Technology, BioSyM, Singapore, Singapore, Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, NUS Graduate School for Integrative Sciences, National University of Singapore, Singapore, Singapore, NUS Tissue-Engineering Programme, National University of Singapore, Singapore, Singapore, Department of Mechanical Engineering and Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America
⨯
Predicting In Vivo Anti-Hepatofibrotic Drug Efficacy Based on In Vitro High-Content Analysis
- Baixue Zheng,
- Looling Tan,
- Xuejun Mo,
- Weimiao Yu,
- Yan Wang,
- Lisa Tucker-Kellogg,
- Roy E. Welsch,
- Peter T. C. So,
- Hanry Yu
- Published: November 2, 2011
- https://doi.org/10.1371/journal.pone.0026230